Literature DB >> 8879640

Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia.

G Rondón1, S Giralt, Y Huh, I Khouri, B Andersson, M Andreeff, R Champlin.   

Abstract

We report the case of a patient with chronic lymphocytic leukemia (CLL) with persistent lymphocytosis and lymphadenopathy after allogeneic bone marrow transplantation (BMT). After receiving a donor lymphocyte infusion on day 87 he achieved complete remission upon development of chronic graft-versus-host disease, suggesting that a graft-versus-leukemia effect is operative in this malignancy.

Entities:  

Mesh：

Year:  1996        PMID： 8879640

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  17 in total

Review 1.  Adoptive T-cell immunotherapy of chronic lymphocytic leukaemia.

Authors:  Aaron E Foster; Malcolm K Brenner; Gianpietro Dotti
Journal:  Best Pract Res Clin Haematol       Date:  2008-09       Impact factor: 3.020

2.  Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation Failure.

Authors:  Uri Rozovski; Ohad Benjamini; Preetesh Jain; Philip A Thompson; William G Wierda; Susan O'Brien; Jan A Burger; Alessandra Ferrajoli; Stefan Faderl; Elizabeth Shpall; Chitra Hosing; Issa F Khouri; Richard Champlin; Michael J Keating; Zeev Estrov
Journal:  J Clin Oncol       Date:  2015-04-06       Impact factor: 44.544

3.  Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study.

Authors:  M van Gelder; M H van Oers; W G Alemayehu; M C J Abrahamse-Testroote; J J Cornelissen; M E Chamuleau; P Zachée; M Hoogendoorn; M Nijland; E J Petersen; A Beeker; G-J Timmers; L Verdonck; M Westerman; O de Weerdt; A P Kater
Journal:  Bone Marrow Transplant       Date:  2016-02-15       Impact factor: 5.483

4.  Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome.

Authors:  Issa F Khouri; Roland Bassett; Nancy Poindexter; Susan O'Brien; Carlos E Bueso-Ramos; Yvonne Hsu; Alessandra Ferrajoli; Michael J Keating; Richard Champlin; Marcelo Fernandez-Vina
Journal:  Cancer       Date:  2011-03-31       Impact factor: 6.860

Review 5.  Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens.

Authors:  R Champlin; S Giralt; I Khouri
Journal:  Curr Oncol Rep       Date:  2000-03       Impact factor: 5.075

6.  NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  David L Porter; Edwin P Alyea; Joseph H Antin; Marcos DeLima; Eli Estey; J H Frederik Falkenburg; Nancy Hardy; Nicolaus Kroeger; Jose Leis; John Levine; David G Maloney; Karl Peggs; Jacob M Rowe; Alan S Wayne; Sergio Giralt; Michael R Bishop; Koen van Besien
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-10       Impact factor: 5.742

Review 7.  Utilizing cell-based therapeutics to overcome immune evasion in hematologic malignancies.

Authors:  Chuang Sun; Gianpietro Dotti; Barbara Savoldo
Journal:  Blood       Date:  2016-05-20       Impact factor: 22.113

8.  Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantation.

Authors:  Lucia Farina; Cristiana Carniti; Anna Dodero; Antonio Vendramin; Anna Raganato; Francesco Spina; Francesca Patriarca; Franco Narni; Fabio Benedetti; Attilio Olivieri; Paolo Corradini
Journal:  Haematologica       Date:  2009-04-18       Impact factor: 9.941

Review 9.  Review of "minitransplantation": nonmyeloablative allogeneic hematopoietic stem cell transplantation.

Authors:  George E Georges; Rainer Storb
Journal:  Int J Hematol       Date:  2003-01       Impact factor: 2.490

Review 10.  Graft-versus-leukemia effect of nonmyeloablative stem cell transplantation.

Authors:  Masahiro Imamura; Junji Tanaka
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 3.165
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.